Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 5057-12-5 | MDL No. : | MFCD01111799 |
Formula : | C9H11NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KNRFNTVMEIIKEB-UHFFFAOYSA-N |
M.W : | 165.19 | Pubchem ID : | 293641 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.56 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 47.79 |
TPSA : | 46.17 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.47 cm/s |
Log Po/w (iLOGP) : | 1.41 |
Log Po/w (XLOGP3) : | -0.23 |
Log Po/w (WLOGP) : | 0.52 |
Log Po/w (MLOGP) : | 0.39 |
Log Po/w (SILICOS-IT) : | 1.85 |
Consensus Log Po/w : | 0.79 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.72 |
Solubility : | 31.5 mg/ml ; 0.191 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.28 |
Solubility : | 86.3 mg/ml ; 0.522 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.17 |
Solubility : | 1.12 mg/ml ; 0.00679 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.93 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92.7% | With N-Bromosuccinimide In cyclohexane for 3 h; Cooling with ice; Reflux | To a 100 ml three-necked flask were added 3,4,7,8-tetrahydro-2,5 (1 H, 6Η) -quinoline dione (0.02 mol) and cyclohexane (25 ml) After stirring to dissolve in the ice bath for 10min, slowly add dropwise a solution of N-bromosuccinimide (0.03mol) in cyclohexane (5ml), and reflux for 3h at the end of the dropwise addition. After completion of the reaction by TLC, cool down to room temperature . Water was added (amount was 0.7 times the volume of the reactant), and the mixture was allowed to stand with stirring. The aqueous layer was extracted with ethyl acetate (1 × the volume of the aqueous layer 4 times), and the organic layers were combined. Anhydrous sulfuric acid Calcium was dried and filtered, the filtrate was evaporated to remove the solvent, and the residue was dried to give an off-white solid as a 5-hydroxy-Dihydro-2 (1H) -quinolone (Yield 92.7percent), mp 233 ~ 234 °C, BP2013-HPLC method chromatography purity 94.3percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | at 80℃; for 5 h; Inert atmosphere | General procedure: 1,3-Dicarbonyls (8.9 mmol, 1 equiv.) followed by ammonium acetate (10.6 mmol, 1.2 mmol, 1.2 equiv.) were added to the solution of acrylic acid (10.6 mmol, 1.2 equiv.). The reactant mass was mixed thoroughly with a spatula and heated at 80 °C with stirring under a nitrogen atmosphere for 5 h. After cooling, the reaction mixture was diluted with 10mL distilled water and extracted twice with ethyl acetate (210 mL). The organic extracts were dried over anhydrous Na2SO4. After filtration, the solvent was evaporated under reduced pressure and subjected to column chromatography (ethyl acetate=hexane) to obtain pure products. The characterization data of the compounds are given. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90.2% | for 6 h; Reflux | -amino-2-cyclohexenone (0.02mol) and acrylic acid (0.024mol) was added to a 100ml three-necked flask, heated to reflux with stirring 6h, cooled to room temperature, the reaction solution was solidified to give a reddish brown solid , Adding absolute ethanol (5ml), heating and dissolving, cooling to room temperature, filtering and drying the filter cake to obtain light yellow crystal which is 3,4,7,8-tetrahydro-2,5 (1H, 6H) Ketone (yield 90.2percent), |
[ 88611-67-0 ]
N-(5-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
Similarity: 0.75
[ 22246-13-5 ]
6-Amino-3,4-dihydroquinolin-2(1H)-one
Similarity: 0.74
[ 4424-80-0 ]
4,5-Dihydro-1H-benzo[b]azepin-2(3H)-one
Similarity: 0.74
[ 13754-86-4 ]
6,7-Dihydro-1H-indol-4(5H)-one
Similarity: 0.77
[ 56008-20-9 ]
3,6,6-Trimethyl-6,7-dihydro-1H-indol-4(5H)-one
Similarity: 0.76
[ 88611-67-0 ]
N-(5-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
Similarity: 0.75
[ 96293-17-3 ]
(S)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide
Similarity: 0.64
[ 105024-93-9 ]
(R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide
Similarity: 0.64
[ 88069-49-2 ]
N-(2,6-Dimethylphenyl)-2-(hexahydro-1H-pyrrolizin-7a-yl)acetamide hydrochloride
Similarity: 0.62
[ 1211496-23-9 ]
1-(2-Amino-6-methylphenyl)piperidin-2-one
Similarity: 0.62
[ 34595-26-1 ]
2-(Piperidin-1-yl)benzaldehyde
Similarity: 0.60
[ 88069-49-2 ]
N-(2,6-Dimethylphenyl)-2-(hexahydro-1H-pyrrolizin-7a-yl)acetamide hydrochloride
Similarity: 0.62
[ 3647-74-3 ]
3a,4,7,7a-Tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
Similarity: 0.52